These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

823 related items for PubMed ID: 25484578

  • 1. Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.
    Wattmo C, Londos E, Minthon L.
    Clin Interv Aging; 2014; 9():1951-62. PubMed ID: 25484578
    [Abstract] [Full Text] [Related]

  • 2. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
    Wattmo C, Minthon L, Wallin ÅK.
    Alzheimers Res Ther; 2016 Feb 17; 8():7. PubMed ID: 26883213
    [Abstract] [Full Text] [Related]

  • 3. Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death.
    Wattmo C, Londos E, Minthon L.
    BMC Neurol; 2016 Aug 31; 16(1):156. PubMed ID: 27581368
    [Abstract] [Full Text] [Related]

  • 4. A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy.
    Wattmo C, Paulsson E, Minthon L, Londos E.
    Clin Interv Aging; 2013 Aug 31; 8():329-39. PubMed ID: 23682212
    [Abstract] [Full Text] [Related]

  • 5. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
    Wattmo C, Wallin ÅK.
    Alzheimers Res Ther; 2017 Aug 31; 9(1):70. PubMed ID: 28859660
    [Abstract] [Full Text] [Related]

  • 6. Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil.
    Hatoum HT, Thomas SK, Lin SJ, Lane R, Bullock R.
    J Med Econ; 2009 Jun 31; 12(2):98-103. PubMed ID: 19492974
    [Abstract] [Full Text] [Related]

  • 7. Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.
    Wattmo C, Londos E, Minthon L.
    Curr Alzheimer Res; 2018 Jun 31; 15(10):905-916. PubMed ID: 29732972
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.
    Wattmo C, Wallin AK, Londos E, Minthon L.
    Gerontologist; 2011 Feb 31; 51(1):17-27. PubMed ID: 20562471
    [Abstract] [Full Text] [Related]

  • 9. Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: a 2-year prospective study in 686 patients of the REAL.FR study.
    Sourdet S, van Kan GA, Soto ME, Houles M, Cantet C, Nourhashemi F, Vellas B, Pahor M, Rolland Y.
    J Am Med Dir Assoc; 2012 May 31; 13(4):407.e1-6. PubMed ID: 22227074
    [Abstract] [Full Text] [Related]

  • 10. Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort.
    Wattmo C, Wallin AK, Minthon L.
    BMC Neurol; 2012 Nov 05; 12():134. PubMed ID: 23126532
    [Abstract] [Full Text] [Related]

  • 11. Predictors of nursing home admission among Alzheimer's disease patients with psychosis and/or agitation.
    Miller EA, Schneider LS, Rosenheck RA.
    Int Psychogeriatr; 2011 Feb 05; 23(1):44-53. PubMed ID: 20214847
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec 05; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment.
    Wattmo C, Wallin ÅK, Londos E, Minthon L.
    Alzheimer Dis Assoc Disord; 2011 Dec 05; 25(1):63-72. PubMed ID: 20847636
    [Abstract] [Full Text] [Related]

  • 14. Factors associated with ADL/IADL disability in community dwelling older adults in the Irish longitudinal study on ageing (TILDA).
    Connolly D, Garvey J, McKee G.
    Disabil Rehabil; 2017 Apr 05; 39(8):809-816. PubMed ID: 27045728
    [Abstract] [Full Text] [Related]

  • 15. Cognitive Aging Trajectories and Burdens of Disability, Hospitalization and Nursing Home Admission Among Community-living Older Persons.
    Han L, Gill TM, Jones BL, Allore HG.
    J Gerontol A Biol Sci Med Sci; 2016 Jun 05; 71(6):766-71. PubMed ID: 26511011
    [Abstract] [Full Text] [Related]

  • 16. Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study.
    Bellelli G, Lucchi E, Minicuci N, Rozzini L, Bianchetti A, Padovani A, Trabucchi M.
    Aging Clin Exp Res; 2005 Feb 05; 17(1):54-61. PubMed ID: 15847123
    [Abstract] [Full Text] [Related]

  • 17. Neuropsychiatric Symptoms in Alzheimer's Disease Are the Main Determinants of Functional Impairment in Advanced Everyday Activities.
    Delgado C, Vergara RC, Martínez M, Musa G, Henríquez F, Slachevsky A.
    J Alzheimers Dis; 2019 Feb 05; 67(1):381-392. PubMed ID: 30584142
    [Abstract] [Full Text] [Related]

  • 18. Living alone with Alzheimer's disease: cross-sectional and longitudinal analysis in the REAL.FR Study.
    Nourhashemi F, Amouyal-Barkate K, Gillette-Guyonnet S, Cantet C, Vellas B, REAL.FR Group.
    J Nutr Health Aging; 2005 Feb 05; 9(2):117-20. PubMed ID: 15791356
    [Abstract] [Full Text] [Related]

  • 19. Interrelationship of oral health status, swallowing function, nutritional status, and cognitive ability with activities of daily living in Japanese elderly people receiving home care services due to physical disabilities.
    Furuta M, Komiya-Nonaka M, Akifusa S, Shimazaki Y, Adachi M, Kinoshita T, Kikutani T, Yamashita Y.
    Community Dent Oral Epidemiol; 2013 Apr 05; 41(2):173-81. PubMed ID: 22934613
    [Abstract] [Full Text] [Related]

  • 20. Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services.
    Wattmo C, Londos E, Minthon L.
    Dement Geriatr Cogn Disord; 2015 Apr 05; 40(5-6):297-310. PubMed ID: 26335053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.